A Multi-Center, Prospective, First-in-Human Study to Evaluate the Initial Safery and Effectiveness of a Symptomatic Massive Rotator Cuff Tear

Title

Code

053CLD

Type

Indagine clinica con Dispositivo Medico

Start Year

2025

Status

In Corso

Principal Investigator

051-6366111 (centralino)

stefano.zaffagnini@unibo.it

Zaffagnini Stefano, MD

Director

2nd Orthopaedic and Traumatologic Clinic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica II

Director

Zaffagnini Stefano, MD

Go to the details >>

Description

Studio clinico promosso da Voll Medical Technologuies Ltd.

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. 053CLD

Wednesday 3 December 2025, 16:32

PG0016860_2025_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

A Multi-Center, Prospective, First-in-Human Study to Evaluate the Initial Safery and Effectiveness of a Symptomatic Massive Rotator Cuff Tear

Principal Investigator

Operational unit that carry out the study

Description

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

A Multi-Center, Prospective, First-in-Human Study to Evaluate the Initial Safery and Effectiveness of a Symptomatic Massive Rotator Cuff Tear

Principal Investigator

Operational unit that carry out the study

Description

Documents and Videos attachament

You might also be interested in